Topic

Virginia

A collection of 501 issues

How to Get Opsumit (Macitentan) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization and Appeals Guide 2025

Answer Box: Getting Opsumit Covered in Virginia Opsumit (macitentan) requires prior authorization from Aetna CVS Health for pulmonary arterial hypertension (PAH). Key steps: 1) Have your PAH specialist document WHO Group 1 PAH diagnosis with NYHA/WHO functional class, 2) Complete step therapy requirements (typically ambrisentan or bosentan trial), and

Get Juxtapid (Lomitapide) Covered by Cigna in Virginia: Complete Guide to Prior Authorization, Appeals, and Cost Assistance

Answer Box: Getting Juxtapid Covered by Cigna in Virginia Yes, Cigna covers Juxtapid (lomitapide) in Virginia with prior authorization for homozygous familial hypercholesterolemia (HoFH). The fastest path to approval requires: (1) genetic or clinical HoFH documentation, (2) proof of failed PCSK9 inhibitor therapy, (3) baseline liver function tests, and (4)

How to Get Natpara (Parathyroid Hormone) Covered by Blue Cross Blue Shield in Virginia: Complete Requirements Guide and Appeals Process

Answer Box: Getting Natpara Covered by Blue Cross Blue Shield in Virginia Natpara (parathyroid hormone) requires prior authorization from Blue Cross Blue Shield Virginia plans. However, Takeda discontinued global manufacturing in 2024, with U.S. supply ending December 31, 2025. New starts are typically denied due to lack of commercial

How to Get Fintepla (fenfluramine) Covered by Humana in Virginia: Prior Authorization Forms, Appeals, and Step-by-Step Guide

Quick Answer: Getting Fintepla Covered by Humana in Virginia To get Fintepla (fenfluramine) covered by Humana in Virginia, you need prior authorization with specific documentation: confirmed Dravet syndrome or Lennox-Gastaut syndrome diagnosis, evidence of at least two failed antiseizure medications, baseline echocardiogram results, and enrollment in the FDA REMS program.

How to Get Pomalyst (Pomalidomide) Covered by Cigna in Virginia: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Pomalyst (Pomalidomide) Covered by Cigna in Virginia Eligibility: Cigna covers Pomalyst (pomalidomide) for multiple myeloma patients 18+ who've tried at least one prior antimyeloma therapy and are enrolled in the REMS program. Fastest approval path: Have your oncologist submit prior authorization through Cigna's

If Pombiliti (Cipaglucosidase Alfa-Atga) Isn't Approved by Cigna in Virginia: Formulary Alternatives & Exception Paths

Quick Answer: If Cigna denies Pombiliti (cipaglucosidase alfa-atga) coverage in Virginia, you'll likely need to try formulary alternatives like Lumizyme or Nexviazyme first due to step therapy requirements. Document any treatment failures carefully—this evidence becomes crucial for later exception requests or appeals. Virginia's external review

How to Get Elzonris (Tagraxofusp-erzs) Covered by UnitedHealthcare in Virginia: Complete PA Guide and Appeals Process

Answer Box: Quick Path to Coverage To get Elzonris (tagraxofusp-erzs) covered by UnitedHealthcare in Virginia: You need confirmed CD123-positive BPDCN diagnosis, baseline labs showing albumin ≥3.2 g/dL, and a detailed capillary leak syndrome monitoring plan. Submit prior authorization through the UnitedHealthcare Provider Portal with pathology report, clinical notes,

Myths vs. Facts: Getting Busulfex (busulfan injection) Covered by Blue Cross Blue Shield in Virginia

Quick Answer: Getting Busulfex Covered by Blue Cross Blue Shield in Virginia Yes, Blue Cross Blue Shield (BCBS) Virginia covers Busulfex (busulfan injection) for FDA-approved transplant conditioning, but prior authorization is typically required. Most denials stem from missing documentation or procedural errors, not medical necessity. Your fastest path: 1) Verify

How to Get Trikafta Covered by Aetna CVS Health in Virginia: Complete Prior Authorization and Appeals Guide 2024

Answer Box: Getting Trikafta Covered by Aetna CVS Health in Virginia Trikafta requires prior authorization from Aetna CVS Health in Virginia. Submit complete documentation including CFTR genotype testing showing F508del mutation, CF diagnosis with ICD-10 codes E84.0-E84.9, and baseline liver function tests. If denied, appeal within 180 days

Renewing iLink® Corneal Cross-Linking Coverage with UnitedHealthcare in Virginia: Timeline, Documentation & Appeals Guide

Quick Answer: Renewing Your iLink® Coverage UnitedHealthcare requires annual prior authorization renewal for iLink® corneal cross-linking. Start the renewal process 4-6 weeks before your current authorization expires. You'll need updated corneal topography showing continued progression, a medical necessity letter from your ophthalmologist, and evidence of treatment response. Submit